We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Inovio Starts Phase 2 Trial Segment for Potential COVID-19 Vaccine
Inovio Starts Phase 2 Trial Segment for Potential COVID-19 Vaccine
Inovio has launched the phase 2 portion of its phase 2/3 clinical trial evaluating INO-4800, a potential coronavirus vaccine funded by the Department of Defense (DoD).